Clinical Study
One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration
Table 3
Changes in visual acuity after PDT combined with IVR during 12 months.
| Changes in logMAR from the baseline | 1 month | 3 months | 6 months | 12 months |
| 0.3 logMAR units improvement | 7 eyes (18.4%) | 16 eyes (42.1%) | 14 eyes (36.8%) | 15 eyes (39.5%) | Changes under 0.3 logMAR units | 30 eyes (78.9%) | 21 eyes (55.3%) | 23 eyes (60.5%) | 21 eyes (55.3%) | ≧0.3 logMAR units deterioration | 1 eye (2.6%) | 1 eye (2.6%) | 1 eye (2.6%) | 2 eyes (5.3%) |
|
|
IVR: intravitreal injection of ranibizumab, PDT: photodynamic therapy.
|